source
- FDA approves OTC naloxone nasal spray Rextovy, expanding consumer access to overdose treatmentThe FDA announced approval of a new over-the-counter naloxone nasal spray called Rextovy, delivering 4 mg of naloxone hydrochloride for emergency reversal of opioid overdose. The product can be pu…
- FDA gives modest backing to Moderna’s flu vaccine, noting efficacy questions but no major concernsThe FDA released briefing documents ahead of an advisory committee meeting on Moderna’s seasonal influenza vaccine. The agency’s assessment was described as tepid, highlighting some questions abou…